Literature DB >> 16133873

Insulin-like growth factor-I induces the phosphorylation and nuclear exclusion of forkhead transcription factors in human neuroblastoma cells.

T S Schwab1, B B Madison, A R Grauman, E L Feldman.   

Abstract

Akt-mediated phosphorylation of forkhead transcription factors is linked to growth factor-stimulated cell survival. We investigated whether the survival activity of insulin-like growth factor-I (IGF-I) in SH-SY5Y human neuroblastoma (NBL) cells is associated with phosphorylation and/or localization changes in forkhead proteins. IGF-I induced phosphorylation of Erks (p42/p44), FKHR (FOXO1a) (Ser 253), FKHRL1 (FOXO3a) (Ser 256), and Akt (Ser 473). PI3-K inhibitor, LY294002, reduced IGF-I-stimulated phosphorylation of FKHR, FKHRL1, and Akt, but did not affect Erk phosphorylation. Using a GFP-FKHR construct, FKHR imported into the nucleus during growth factor withdrawal-induced apoptosis. In addition, IGF-I rescue from serum withdrawal-induced apoptosis is associated with a rapid export of GFP-FKHR into the cytoplasm. Leptomycin B, an inhibitor of Crm1-mediated nuclear export, decreased the level of FKHRL1 phosphorylation in the presence of IGF-I in vector and FKHR overexpressing cells, but had no effect on the phosphorylation status of FKHR. In addition, leptomycin B prevented IGF-I stimulated nuclear export of GFP-FKHR. These studies show IGF-I phosphorylation of FKHR and FKHRL1 via a PI3-K-dependent pathway in NBL cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133873     DOI: 10.1007/s10495-005-0429-y

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  15 in total

1.  Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells.

Authors:  Gang Xi; Xinchun Shen; Yashwanth Radhakrishnan; Laura Maile; David Clemmons
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

2.  Testing of the Akt/PKB inhibitor MK-2206 by the Pediatric Preclinical Testing Program.

Authors:  Richard Gorlick; John M Maris; Peter J Houghton; Richard Lock; Hernan Carol; Raushan T Kurmasheva; E Anders Kolb; Stephen T Keir; C Patrick Reynolds; Min H Kang; Catherine A Billups; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2011-11-18       Impact factor: 3.167

3.  IGF-1 protects intestinal epithelial cells from oxidative stress-induced apoptosis.

Authors:  Naira Baregamian; Jun Song; Marc G Jeschke; B Mark Evers; Dai H Chung
Journal:  J Surg Res       Date:  2006-09-26       Impact factor: 2.192

4.  PARP1 inhibitors attenuate AKT phosphorylation via the upregulation of PHLPP1.

Authors:  Shuai Wang; Huibo Wang; Ben C Davis; Jiyong Liang; Rutao Cui; Sai-Juan Chen; Zhi-Xiang Xu
Journal:  Biochem Biophys Res Commun       Date:  2011-07-29       Impact factor: 3.575

5.  Patterning N-type and S-type neuroblastoma cells with Pluronic F108 and ECM proteins.

Authors:  Joseph M Corey; Caitlyn C Gertz; Thomas J Sutton; Qiaoran Chen; Katherine B Mycek; Bor-Shuen Wang; Abbey A Martin; Sara L Johnson; Eva L Feldman
Journal:  J Biomed Mater Res A       Date:  2010-05       Impact factor: 4.396

6.  The effect of an NgR1 antagonist on the neuroprotection of cortical axons after cortical infarction in rats.

Authors:  Hong Zhan; Shu-Jie Sun; Jie Cai; Ying-Qing Li; Chun-Lin Hu; Daniel H S Lee; Kwok-Fai So; Xin Li
Journal:  Neurochem Res       Date:  2013-03-24       Impact factor: 3.996

7.  Hydrogen peroxide-induced Akt phosphorylation regulates Bax activation.

Authors:  Mahdieh Sadidi; Stephen I Lentz; Eva L Feldman
Journal:  Biochimie       Date:  2009-02-06       Impact factor: 4.079

8.  Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing program.

Authors:  Hernan Carol; Christopher L Morton; Richard Gorlick; E Anders Kolb; Stephen T Keir; C Patrick Reynolds; Min H Kang; John M Maris; Catherine Billups; Malcolm A Smith; Peter J Houghton; Richard B Lock
Journal:  Pediatr Blood Cancer       Date:  2010-08-25       Impact factor: 3.167

9.  Remote neurotrophic support of epidermal nerve fibres in experimental diabetes.

Authors:  C Toth; V Brussee; D W Zochodne
Journal:  Diabetologia       Date:  2006-03-10       Impact factor: 10.122

10.  Mesenchymal-epithelial transition in epithelial response to injury: the role of Foxc2.

Authors:  C Hader; A Marlier; L Cantley
Journal:  Oncogene       Date:  2009-11-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.